Literature DB >> 2786201

Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA.

D Ginsburg1, B A Konkle, J C Gill, R R Montgomery, P L Bockenstedt, T A Johnson, A Y Yang.   

Abstract

von Willebrand disease (vWD), the most common inherited bleeding disorder in humans, can result from either a quantitative or a qualitative defect in the adhesive glycoprotein, von Willebrand factor (vWF). Molecular studies of vWD have been limited by the large size of the vWF gene and difficulty in obtaining the vWF mRNA from patients. By use of an adaptation of the polymerase chain reaction, vWF mRNA was amplified and sequenced from peripheral blood platelets. A silent vWF allele was identified, resulting from a cis defect in vWF mRNA transcription or processing. In two type IIA vWD patients, two different but adjacent missense mutations were identified, the locations of which may identify an important vWF functional domain. Expression in heterologous cells of recombinant vWF containing one of these latter mutations reproduced the characteristic structural abnormality seen in type IIA vWD plasma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2786201      PMCID: PMC287212          DOI: 10.1073/pnas.86.10.3723

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Nucleotide sequence of pre-pro-von Willebrand factor cDNA.

Authors:  D Bonthron; E C Orr; L M Mitsock; D Ginsburg; R I Handin; S H Orkin
Journal:  Nucleic Acids Res       Date:  1986-09-11       Impact factor: 16.971

2.  Enzymatic amplification of platelet-specific messenger RNA using the polymerase chain reaction.

Authors:  P J Newman; J Gorski; G C White; S Gidwitz; C J Cretney; R H Aster
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

3.  Cleavage of human von Willebrand factor by platelet calcium-activated protease.

Authors:  T J Kunicki; R R Montgomery; J Schullek
Journal:  Blood       Date:  1985-02       Impact factor: 22.113

4.  Biosynthesis of major platelet proteins in human blood platelets.

Authors:  N Kieffer; J Guichard; J P Farcet; W Vainchenker; J Breton-Gorius
Journal:  Eur J Biochem       Date:  1987-04-01

5.  Structure of pre-pro-von Willebrand factor and its expression in heterologous cells.

Authors:  D T Bonthron; R I Handin; R J Kaufman; L C Wasley; E C Orr; L M Mitsock; B Ewenstein; J Loscalzo; D Ginsburg; S H Orkin
Journal:  Nature       Date:  1986 Nov 20-26       Impact factor: 49.962

6.  The heterogeneity of type IIA von Willebrand's disease: studies with protease inhibitors.

Authors:  J Batlle; M F Lopez Fernandez; M Campos; B Justica; C Berges; J L Navarro; J M Diaz Cremades; C K Kasper; J A Dent; Z M Ruggeri
Journal:  Blood       Date:  1986-12       Impact factor: 22.113

7.  Epidemiological investigation of the prevalence of von Willebrand's disease.

Authors:  F Rodeghiero; G Castaman; E Dini
Journal:  Blood       Date:  1987-02       Impact factor: 22.113

8.  In vitro correction of the abnormal multimeric structure of von Willebrand factor in type IIa von Willebrand's disease.

Authors:  H R Gralnick; S B Williams; L P McKeown; P Maisonneuve; C Jenneau; Y Sultan; M E Rick
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

9.  Epitope mapping of the von Willebrand factor subunit distinguishes fragments present in normal and type IIA von Willebrand disease from those generated by plasmin.

Authors:  S D Berkowitz; J Dent; J Roberts; Y Fujimura; E F Plow; K Titani; Z M Ruggeri; T S Zimmerman
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

10.  Full-length von Willebrand factor (vWF) cDNA encodes a highly repetitive protein considerably larger than the mature vWF subunit.

Authors:  C L Verweij; P J Diergaarde; M Hart; H Pannekoek
Journal:  EMBO J       Date:  1986-08       Impact factor: 11.598

View more
  22 in total

1.  Germ-line mosaicism for a valine-to-methionine substitution at residue 553 in the glycoprotein Ib-binding domain of von Willebrand factor, causing type IIB von Willebrand disease.

Authors:  E W Murray; A R Giles; D Lillicrap
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

Review 2.  Application of the polymerase chain reaction to the diagnosis of human genetic disease.

Authors:  J Reiss; D N Cooper
Journal:  Hum Genet       Date:  1990-06       Impact factor: 4.132

3.  Detection of Philadelphia chromosome-positive cells from glass slide smears using the polymerase chain reaction.

Authors:  C A Hanson; E A Holbrook; S Sheldon; B Schnitzer; M S Roth
Journal:  Am J Pathol       Date:  1990-07       Impact factor: 4.307

4.  Defective dimerization of von Willebrand factor subunits due to a Cys-> Arg mutation in type IID von Willebrand disease.

Authors:  R Schneppenheim; J Brassard; S Krey; U Budde; T J Kunicki; L Holmberg; J Ware; Z M Ruggeri
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

5.  Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa.

Authors:  L De Marco; M Mazzucato; D De Roia; A Casonato; A B Federici; A Girolami; Z M Ruggeri
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

6.  Severe von Willebrand disease due to a defect at the level of von Willebrand factor mRNA expression: detection by exonic PCR-restriction fragment length polymorphism analysis.

Authors:  W C Nichols; S E Lyons; J S Harrison; R L Cody; D Ginsburg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

7.  von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure.

Authors:  L Holmberg; J A Dent; R Schneppenheim; U Budde; J Ware; Z M Ruggeri
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

8.  Genetic and blood coagulation characterization of "Swedish" families with von Willebrand's disease types I and III: new aspects of heredity.

Authors:  M Anvret; M Blombäck; M Lindstedt; E Söderlind; M Tapper-Persson; A C Thelander
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

9.  Proteolytic processing of von Willebrand factor subunit: heterogeneity in type-IIA von Willebrand disease.

Authors:  J Batlle; J Lasierra; A F Villamor; J L Navarro; A Pardo; M Campos; B Justiça; M F López Fernández
Journal:  Ann Hematol       Date:  1994-03       Impact factor: 3.673

10.  Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit.

Authors:  J A Dent; M Galbusera; Z M Ruggeri
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.